Trial
NCT07364487
This is an Open-Label Study to Assess the Safety and Efficacy of GC012F in Patients With Multiple Sclerosis
Early Phase IWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Huashan Hospital
Collaborators
—
Condition
Multiple Sclerosis
Intervention
GC012F CAR-T Cell Injection
Why stopped
Due to the sponsor's adjustment of the research and development strategy for this clinical trial, this study was prematurely terminated, and no subjects were recruited for this study.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-03-30